nVerses Capital’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
nVerses Capital's ALT Position: Q3 2026 in Review
nVerses Capital sold out of Altimmune (ALT) in Q3 2026, closing a stake of 24,408 shares — an estimated $74.2K sold.
nVerses Capital first reported a position in ALT in Q2 2026 and held it in 1 quarter. The position peaked at $74.2K in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- nVerses Capital reported no remaining Altimmune position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 24,408 Altimmune shares in Q3 2026, an estimated $74.2K.
- nVerses Capital first reported a position in Altimmune in Q2 2026 and held it in 1 quarter.
- nVerses Capital's Altimmune position peaked at $74.2K in Q2 2026.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.